BNP Paribas Financial Markets’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.8K Buy
16,773
+9,294
+124% +$13.2K ﹤0.01% 3709
2025
Q1
$11.4K Buy
7,479
+6,033
+417% +$9.23K ﹤0.01% 3854
2024
Q4
$3.59K Sell
1,446
-1,822
-56% -$4.52K ﹤0.01% 4111
2024
Q3
$3.76K Sell
3,268
-131
-4% -$151 ﹤0.01% 3126
2024
Q2
$3.74K Sell
3,399
-237,702
-99% -$261K ﹤0.01% 3105
2024
Q1
$299K Buy
241,101
+23,747
+11% +$29.4K ﹤0.01% 2459
2023
Q4
$228K Buy
217,354
+140,744
+184% +$148K ﹤0.01% 2455
2023
Q3
$525K Buy
76,610
+46,064
+151% +$316K ﹤0.01% 2065
2023
Q2
$317K Sell
30,546
-6,395
-17% -$66.3K ﹤0.01% 2216
2023
Q1
$299K Buy
36,941
+27,947
+311% +$226K ﹤0.01% 2369
2022
Q4
$142K Sell
8,994
-12,080
-57% -$190K ﹤0.01% 2477
2022
Q3
$332K Buy
21,074
+7,717
+58% +$121K ﹤0.01% 2559
2022
Q2
$186K Buy
13,357
+8,931
+202% +$125K ﹤0.01% 2492
2022
Q1
$76.3K Sell
4,426
-6,426
-59% -$111K ﹤0.01% 2875
2021
Q4
$158K Buy
10,852
+1,823
+20% +$26.5K ﹤0.01% 2828
2021
Q3
$163K Buy
9,029
+7,373
+445% +$133K ﹤0.01% 2534
2021
Q2
$29.1K Buy
+1,656
New +$29.1K ﹤0.01% 2845
2020
Q3
Sell
-10,655
Closed -$17.3K 3580
2020
Q2
$17.3K Buy
10,655
+24
+0.2% +$39 ﹤0.01% 2837
2020
Q1
$11.1K Buy
10,631
+2,906
+38% +$3.02K ﹤0.01% 3396
2019
Q4
$14.6K Buy
7,725
+2,206
+40% +$4.17K ﹤0.01% 3406
2019
Q3
$5.96K Buy
5,519
+1,525
+38% +$1.65K ﹤0.01% 3602
2019
Q2
$8.75K Sell
3,994
-3,413
-46% -$7.48K ﹤0.01% 3502
2019
Q1
$44.4K Buy
7,407
+7,398
+82,200% +$44.3K ﹤0.01% 2980
2018
Q4
$67 Sell
9
-838
-99% -$6.24K ﹤0.01% 3545
2018
Q3
$12.3K Hold
847
﹤0.01% 2971
2018
Q2
$16.9K Sell
847
-4,095
-83% -$81.8K ﹤0.01% 2914
2018
Q1
$86.6K Buy
4,942
+49
+1% +$858 ﹤0.01% 2689
2017
Q4
$121K Buy
4,893
+2,905
+146% +$71.6K ﹤0.01% 2552
2017
Q3
$51.3K Sell
1,988
-74
-4% -$1.91K ﹤0.01% 2680
2017
Q2
$55.9K Buy
2,062
+2,037
+8,148% +$55.2K ﹤0.01% 2663
2017
Q1
$746 Sell
25
-655
-96% -$19.5K ﹤0.01% 3176
2016
Q4
$18.5K Sell
680
-17
-2% -$461 ﹤0.01% 2703
2016
Q3
$17.9K Buy
697
+350
+101% +$8.96K ﹤0.01% 2956
2016
Q2
$6.41K Buy
+347
New +$6.41K ﹤0.01% 3140
2016
Q1
Sell
-1,038
Closed -$28K 2663
2015
Q4
$28K Buy
+1,038
New +$28K ﹤0.01% 3157